[1] |
Anania G, Resta G, Marino S, et al. Treatment of colorectal cancer: a multidisciplinary approach[J]. J Gastrointest Cancer, 2019, 50(3): 458-468. DOI: 10.1007/s12029-018-0100-9. doi:10.1007/s12029-018-0100-9pmid:29656351 |
[2] |
葛剑力, 龚玮琦, 滕丽莉, 等. 全科医生视角下多学科诊疗模式探索[J]. 中国初级卫生保健, 2022, 36(3): 117-119. DOI: 10.3969/j.issn.1001-568X.2022.03.0035. doi:10.3969/j.issn.1001-568X.2022.03.0035 |
[3] |
匡晶晶, 苗毅. 一体化多学科协作诊疗模式在胰腺疾病诊疗中的实践[J]. 现代医院, 2021, 21(3): 368-370. DOI: 10.3969/j.issn.1671-332X.2021.03.013. doi:10.3969/j.issn.1671-332X.2021.03.013 |
[4] |
葛静, 张良明, 张千, 等. 多学科诊疗模式在某综合性医院的应用[J]. 安徽预防医学杂志, 2022, 28(1): 86-88. DOI: 10.19837/j.cnki.ahyf.2022.01.019. doi:10.19837/j.cnki.ahyf.2022.01.019 |
[5] |
Kaneko M, Ishihara S, Murono K, et al. Carbohydrate antigen 19-9 predicts synchronous peritoneal carcinomatosis in patients with colorectal cancer[J]. Anticancer Res, 2017, 37(2): 865-870. DOI: 10.21873/anticanres.11391. doi:10.21873/anticanres.11391 |
[6] |
Cremolini C, Loupakis F, Masi G, et al. FOLFOXIRI or FOLFOXIRI plus bevacizumab as first-line treatment of metastatic colorectal cancer: a propensity score-adjusted analysis from two randomized clinical trials[J]. Ann Oncol, 2016, 27(5): 843-849. DOI: 10.1093/annonc/mdw052. doi:10.1093/annonc/mdw052pmid:26861604 |
[7] |
Norén A, Sandström P, Gunnarsdottir K, et al. Identification of inequalities in the selection of liver surgery for colorectal liver metastases in Sweden[J]. Scand J Surg, 2018, 107(4): 294-301. DOI: 10.1177/1457496918766706. doi:10.1177/1457496918766706pmid:29692213 |
[8] |
郑波波, 胡涛, 邓祥兵, 等. MDT在同时性直肠癌肝转移的临床病例实践[J]. 中国普外基础与临床杂志, 2018, 25(3): 342-349. DOI: 10.7507/1007-9424.201712103. doi:10.7507/1007-9424.201712103 |
[9] |
Ren L, Zhu D, Benson AB 3rd, et al. Shanghai international consensus on diagnosis and comprehensive treatment of colorectal liver metastases (version 2019)[J]. Eur J Surg Oncol, 2020, 46(6): 955-966. DOI: 10.1016/j.ejso.2020.02.019. doi:S0748-7983(20)30121-9pmid:32147426 |
[10] |
Okazaki S, Ishikawa T, Uetake H. Perioperative chemotherapies for patients with colorectal liver metastasis[J]. Gan To Kagaku Ryoho, 2020, 47(4): 574-577. |
[11] |
Zhai S, Sun X, Du L, et al. Role of surgical approach to synchronous colorectal liver metastases: a retrospective analysis[J]. Cancer Manag Res, 2021, 13: 3699-3711. DOI: 10.2147/CMAR.S300890. doi:10.2147/CMAR.S300890pmid:33994810 |
[12] |
于冠宇, 王薇, 龚海峰, 等. 乙状结肠癌伴肝巨大转移灶患者的MDT诊疗[J]. 实用肿瘤杂志, 2021, 36(6): 483-489. DOI: 10.13267/j.cnki.syzlzz.2021.097. doi:10.13267/j.cnki.syzlzz.2021.097 |
[13] |
Brännström F, Bjerregaard JK, Winbladh A, et al. Multidisciplinary team conferences promote treatment according to guidelines in rectal cancer[J]. Acta Oncol, 2015, 54(4): 447-453. DOI: 10.3109/0284186X.2014.952387. doi:10.3109/0284186X.2014.952387pmid:25291075 |
[14] |
王玉柳明, 胡汉卿, 王春林, 等. 3例结直肠癌肝转移患者行同期NOSES的MDT诊疗体会[J]. 结直肠肛门外科, 2022, 28(2): 171-176. DOI: 10.19668/j.cnki.issn1674-0491.2022.02.015. doi:10.19668/j.cnki.issn1674-0491.2022.02.015 |
[15] |
张钰洋, 陈善稳, 王鹏远, 等. 结直肠癌肝转移转化治疗的研究进展[J]. 中华胃肠外科杂志, 2021, 24(1): 85-93. DOI: 10.3760/cma.j.cn.441530-20200311-00135. doi:10.3760/cma.j.cn.441530-20200311-00135 |
[16] |
Han L, Xue J, Wu X, et al. Multidisciplinary approach to the diagnosis and treatment of patients with potentially resectable colorectal cancer liver metastasis: results of a multicenter study[J]. Ann Palliat Med, 2022, 11(2): 717-729. DOI: 10.21037/apm-22-87. doi:10.21037/apm-22-87pmid:35249349 |
[17] |
Wang Z, Wang X, Yuan J, et al. Survival benefit of palliative local treatments and efficacy of different pharmacotherapies in colorectal cancer with lung metastasis: results from a large retrospective study[J]. Clin Colorectal Cancer, 2018, 17(2): e233-e255. DOI: 10.1016/j.clcc.2017.12.005. doi:10.1016/j.clcc.2017.12.005 |
[18] |
李原, 林俊忠, 潘志忠. 1例结肠癌疑似肺转移患者的多学科综合治疗决策[J]. 结直肠肛门外科, 2020, 26(1): 102-104. DOI: 10.19668/j.cnki.issn1674-0491.2020.01.027. doi:10.19668/j.cnki.issn1674-0491.2020.01.027 |
[19] |
Siravegna G, Marsoni S, Siena S, et al. Integrating liquid biopsies into the management of cancer[J]. Nat Rev Clin Oncol, 2017, 14(9): 531-548. DOI: 10.1038/nrclinonc.2017.14. doi:10.1038/nrclinonc.2017.14pmid:28252003 |
[20] |
Grothey A, Sobrero AF, Shields AF, et al. Duration of adjuvant chemotherapy for stage Ⅲ colon cancer[J]. N Engl J Med, 2018, 378(13): 1177-1188. DOI: 10.1056/NEJMoa1713709. doi:10.1056/NEJMoa1713709 |
[21] |
Jamil A, Kasi A. Cancer, metastasis to the lung[M]. Treasure Island: Statpearls Publishing, 2020. |
[22] |
Rapicetta C, Lococo F, Davini F, et al. Is adjuvant chemotherapy worthwhile after radical resection for single lung metastasis from colorectal cancer? A multicentric analysis evaluating the risk of recurrence[J]. Front Oncol, 2019, 9: 763. DOI: 10.3389/fonc.2019.00763. doi:10.3389/fonc.2019.00763pmid:31482063 |
[23] |
Nozawa H, Ishihara S, Kawai K, et al. Characterization of conversion chemotherapy for secondary surgical resection in colorectal cancer patients with lung metastases[J]. Oncology, 2017, 92(3): 135-141. DOI: 10.1159/000453335. doi:10.1159/000453335pmid:28052299 |
[24] |
朱万莉, 张润冬, 张亚陆, 等. 结直肠癌肺转移的研究进展[J]. 重庆医学, 2021, 50(4): 689-693. DOI: 10.3969/j.issn.1671-8348.2021.04.033. doi:10.3969/j.issn.1671-8348.2021.04.033 |
[25] |
Vassos N, Piso P. Metastatic colorectal cancer to the peritoneum: current treatment options[J]. Curr Treat Options Oncol, 2018, 19(10): 49. DOI: 10.1007/s11864-018-0563-8. doi:10.1007/s11864-018-0563-8 |
[26] |
Brierley JD, Gospodarowicz MK, Wittekind C. TNM classification of malignant tumours[M]. 8th ed. New York: Wiley-Blackwell, 2017. |
[27] |
孙立峰, 童舟, 丁克峰. 外科肿瘤细胞减灭术联合腹腔内热灌注化疗——结直肠癌腹膜转移治疗的突破方向?[J]. 中华结直肠疾病电子杂志, 2015, 4(3): 234-239. DOI: 10.3877/cma.j.issn.2095-3224.2015.03. doi:10.3877/cma.j.issn.2095-3224.2015.03 |